Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.

[1]  Peter Kraft,et al.  Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques , 2005, Genetic epidemiology.

[2]  T. Pischon,et al.  Inflammatory markers and the risk of coronary heart disease in men and women , 2005 .

[3]  Jing Ma,et al.  Inflammatory markers and the risk of coronary heart disease in men and women. , 2004, The New England journal of medicine.

[4]  W. März,et al.  Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. , 2004, European heart journal.

[5]  Yuetsu Tanaka,et al.  A CCR2-V64I polymorphism affects stability of CCR2A isoform , 2004, AIDS.

[6]  F. Mach,et al.  Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice , 2004, Circulation research.

[7]  E. Rimm,et al.  Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. , 2003, Obesity research.

[8]  J. Drabek,et al.  CC chemokine receptor (CCR)2 polymorphism in Czech patients with myocardial infarction. , 2003, Immunology letters.

[9]  C. Weber,et al.  Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age , 2003, Journal of Molecular Medicine.

[10]  N. Maeda,et al.  CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. , 2003, Atherosclerosis.

[11]  D. Rader,et al.  Val64Ile Polymorphism in the C-C Chemokine Receptor 2 Is Associated With Reduced Coronary Artery Calcification , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[12]  E. Rimm,et al.  Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. , 2002, Clinical chemistry.

[13]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[14]  J. Goedert,et al.  Distribution of Chemokine Receptor CCR2 and CCR5 Genotypes and Their Relative Contribution to Human Immunodeficiency Virus Type 1 (HIV-1) Seroconversion, Early HIV-1 RNA Concentration in Plasma, and Later Disease Progression , 2002, Journal of Virology.

[15]  Z. Prohászka,et al.  Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. , 2001, Atherosclerosis.

[16]  V. Álvarez,et al.  Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction , 2001, Genes and Immunity.

[17]  A. J. Valente,et al.  Evolution of Human and Non-human Primate CC Chemokine Receptor 5 Gene and mRNA , 2000, The Journal of Biological Chemistry.

[18]  Weixin Zhao,et al.  Human Vascular Smooth Muscle Cells Possess Functional CCR5* , 2000, The Journal of Biological Chemistry.

[19]  M J Dolan,et al.  Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. MacDonald,et al.  CCR2-64I Polymorphism Is Not Associated with Altered CCR5 Expression or Coreceptor Function , 1999, Journal of Virology.

[21]  J. Kuratsu,et al.  Cloning and Functional Characterization of the 5′-Flanking Region of the Human Monocyte Chemoattractant Protein-1 Receptor (CCR2) Gene , 1999, The Journal of Biological Chemistry.

[22]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[23]  Walter C. Willett,et al.  Reproducibility and Validity of Food-Frequency Questionnaires , 1998 .

[24]  P. O’Connell,et al.  Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression , 1998, Nature Medicine.

[25]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[26]  S. Mummidi,et al.  The Human CC Chemokine Receptor 5 (CCR5) Gene , 1997, The Journal of Biological Chemistry.

[27]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[28]  P. Murphy.  Chemokine receptors: structure, function and role in microbial pathogenesis. , 1996, Cytokine & growth factor reviews.

[29]  G. Colditz,et al.  The nurses' health study: a cohort of US women followed since 1976. , 1995, Journal of the American Medical Women's Association.

[30]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[31]  R. L. Prentice,et al.  Retrospective studies and failure time models , 1978 .